Microbubbles improve sonothrombolysis in vitro and decrease hemorrhage in vivo in a rabbit stroke model

Investigative Radiology

Volumn 46, Issue 3, 2011, Pages 202-207

  Brown, Aliza T ^a   Flores, Rene ^a   Hamilton, Eric ^a   Roberson, Paula K ^a   Borrelli, Michael J ^a   Culp, William C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

embolic; microbubble; rabbit; stroke; tissue plasminogen activator

Indexed keywords

ALBUMIN; GLUCOSE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOT LYSIS; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; ECHOGRAPHY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INTERNAL CAROTID ARTERY; LOW DRUG DOSE; MICROBUBBLE; NONHUMAN; PARASITE INCIDENCE; PRIORITY JOURNAL; RABBIT;

EID: 79751529767     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e318200757a     Document Type: Article

References (32)

1. Ferris A, Robertson R, Fabunmi R, et al. American heart association and american stroke association national survey of stroke association national survey of stroke risk awareness among women. Circulation. 2005;111:1321-1326. (Pubitemid 40389098)
2. Marler J. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
3. Higashida R, Tsai F, Halbach V, et al. Interventional neurovascular techniques in the treatment of stroke-state of the art therapy. J Intern Med. 1995;237:105-115.
4. Adams H, Brott T, Furlan A, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute stroke. Circulation. 1996;94:1167-1174.
5. Sasaki P, Takeuchi S, Koike T, et al. Fibrinolytic therapy for acute embolic stroke: intravenous, intracarotid, and intra-arterial local approaches. Neurosurgery. 1995;36:246-252.
6. Lyden PD, Zivin JA, Clark WA, et al. Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhage infarction in rabbits. Neurology. 1989;39:703-708. (Pubitemid 19126971)
7. Hacke W, Donnan G, Fieschi C, et al. ATLANTIS trial investigators, ECASS trials investigators, NINDS rt-PA study group investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768-774.
8. Zivin JA. Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the US Food and Drug Administration (FDA). Ann Neurol. 2009;66:6-10.
9. Levy D, Brott T, Haley EC Jr, et al. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke. 1994;25:291-297. (Pubitemid 24047248)
10. Marler JR. Should stroke patients with mild or improving symptoms receive tissue plasminogen activator therapy? Nat Clin Pract Neurol. 2006;2:354-355. (Pubitemid 43983768)
11. Derex L, Nighoghossian N. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J Neurol Neurosurg Psychiatry. 2008;79: 1093-1099.
12. Lansberg MG, Thijs VN, Bammer R, et al. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke. 2007;38: 2275-2278. (Pubitemid 47457568)
13. Molina CA, Barreto AD, Tsivgoulis G, et al. Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial. Ann Neurol. 2009;66:28-38.
14. Wu S, Thornhill RE, Chen S, et al. Relative recirculation: a fast, model-free surrogate for the measurement of blood-brain barrier permeability and the prediction of hemorrhagic transformation in acute ischemic stroke. Invest Radiol. 2009;44:662-668.
15. Tsivgoulis G, Alexandrov AV. Ultrasound-enhanced thrombolysis in acute ischemic stroke: potential, failures, and safety. Neurotherapeutics. 2007;4: 420-427. (Pubitemid 46962421)
16. Daffertshofer M, Gass A, Ringleb P, et al. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial. Stroke. 2005;36:1441-1446. (Pubitemid 40967509)
17. Ribo M, Molina CA, Alvarez B, et al. Intra-arterial administration of micro-bubbles and continuious 2-MHz ultrasound insonation to enhance intra-arterial thrombolysis. J Neuroimaging. 2010;20:224-227.
18. Culp WC, Porter TR, Lowery J, et al. Intracranial clot lysis with intravenous microbubbles and transcranial ultrasound in swine. Stroke. 2004;35:2407-2411. (Pubitemid 39311272)
19. Xie F, Tsutsui JM, Lof J, et al. Effectiveness of lipid microbubbles and ultrasound in declotting thrombosis. Ultrasound Med Biol. 2005;31:979-985. (Pubitemid 40828637)
20. Culp WC, Erdem E, Roberson PK, et al. Microbubble potentiated ultrasound as a method of stroke therapy in a pig model: preliminary findings. J Vasc Interv Radiol. 2003;14:1433-1436. (Pubitemid 37371695)
21. Culp BC, Brown AT, Erdem E, et al. Selective intracranial magnification angiography of the rabbit: basic techniques and anatomy. J Vasc Interv Radiol. 2007;18:187-192. (Pubitemid 46616694)
22. Liang BA, Zivin JA. Empirical characteristics of litigation involving tissue plasminogen activator and ischemic stroke. Ann Emerg Med. 2008;52:160-164.
23. Wang X, Tsuji K, Lee SR, et al. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke. 2004;35:2726-2730. (Pubitemid 39458380)
24. Tabrizi P, Wang L, Seeds N, et al. Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. Arterioscler Thromb Vasc Biol. 1999;19:2801-2806. (Pubitemid 29536061)
25. Cintas P, Nguyen F, Boneu B, et al. Enhancement of enzymatic fibrinolysis with 2-MHz ultrasound and microbubbles. J Thromb Haemost. 2004;2:1163-1166. (Pubitemid 40186090)
26. Molina CA, Ribo M, Rubiera M, et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke. 2006; 37:425-429. (Pubitemid 43731999)
27. Alexandrov AV, Mikulik R, Ribo M, et al. A pilot randomized clinical safety study of thrombolysis augmentation with ultrasound-activated perflutren lipid microspheres. Stroke. 2008;39:1464-1469.
28. Perren F, Loulidi J, Poglia D, et al. Microbubble potentiated transcranial duplex ultrasound enhances IV thrombolysis in acute stroke. J Thromb Thrombolysis. 2008;25:219-223. (Pubitemid 351583671)
29. Larrue V, Viguier A, Arnaud C, et al. Transcranial ultrasound combined with intravenous microbubbles and tissue plasminogen activator for acute ischemic stroke: a randomized controlled study. Stroke. 2007;38:472.
30. Lee SH, Bae HJ, Kwon SJ, et al. Cerebral microbleeds are regionally associated with intracerebral hemorrhage. Neurology. 2004;62:72-76. (Pubitemid 38082873)
31. Fiehler J, Albers GW, Boulanger J-M, et al. Bleeding risk analysis in stroke imaging before thrombolysis (BRASIL) pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke. 2007;38:2738-2744. (Pubitemid 47494012)
32. Viswanathan A, Chabriat H. Cerebral microhemorrhage. Stroke. 2006;37: 550-555. (Pubitemid 43732025)